Jasper Therapeutics, Inc. - 8-K Filing
Jasper Therapeutics implements a 1-for-30 reverse stock split effective November 6, 2026. (Items: 3.03 Material Modification to Rights of Security Holders, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $JSPR
Read the full article at SEC EDGAR
Part of the story NEXGEL, INC. - 8-K Filing (20 articles)